Indevus Pharmaceuticals announced that Sanctura XR (trospium chloride extended release capsules) has been approved by the FDA. Sanctura is indicated for the once-daily treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency.
Product news
Indevus Pharmaceuticals announced that Sanctura XR (trospium chloride extended release capsules) has been approved by the FDA